| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |